Geburtsdatum | Mittwoch, 12. Oktober 1966 |
Sternzeichen | |
Beschreibung | David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space. He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm's life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry. |
